Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
03/10/2004 | CN1480459A Contrast enhancement agent of magnetic resonance imaging radiography for metal fullerene as well as its preparing method and usage |
03/10/2004 | CN1141144C Magnetic contrast medium composition and its preparing method |
03/09/2004 | US6702995 Delivery system |
03/06/2004 | CA2401913A1 Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response |
03/04/2004 | WO2004018456A1 Two-photon absorption heteroaromatic chromophores and compositions thereof |
03/04/2004 | WO2004017967A1 Multifunctional cox-2 inhibitors |
03/04/2004 | WO2004017952A1 Method of treating osteoarthritis |
03/04/2004 | WO2004017943A2 Non-vesicular cationic lipid formulations |
03/04/2004 | WO2004017922A2 Keto cannabinoids with therapeutic indications |
03/04/2004 | WO2004017907A2 Blood clot-targeted nanoparticles |
03/04/2004 | WO2004017905A2 Method and apparatus for noninvasively evaluating endothelial function |
03/04/2004 | WO2003101427A8 Immunoliposomes formed with aggregated antibody |
03/04/2004 | US20040045045 Animal model for toxicology and dose prediction |
03/04/2004 | US20040044294 Skin test device |
03/04/2004 | US20040044076 Neutrophil imaging methods in cystic fibrosis |
03/04/2004 | US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders |
03/04/2004 | US20040043029 Novel antibodies reactive with human carcinomas |
03/04/2004 | US20040042963 Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents |
03/04/2004 | US20040042961 Using mutant green fluorescent protein |
03/04/2004 | US20040042960 Use of moulding compounds for producing treatment devices |
03/04/2004 | US20040042959 Imaging cell death in vivo using non-radionuclide contrast agents |
03/04/2004 | CA2496097A1 Keto cannabinoids with therapeutic indications |
03/04/2004 | CA2495913A1 Non-vesicular cationic lipid formulations |
03/04/2004 | CA2495587A1 Multifunctional cox-2 inhibitors |
03/04/2004 | CA2495050A1 Two-photon absorption heteroaromatic chromophores and compositions thereof |
03/04/2004 | CA2494544A1 Method of treating osteoarthritis |
03/04/2004 | CA2491758A1 Blood clot-targeted nanoparticles |
03/03/2004 | EP1393750A2 Conjugates for treating an immune disease |
03/03/2004 | EP1393719A1 Camptothecin-carboxylate formulations |
03/03/2004 | EP1392666A1 Biologically active methylene blue derivatives |
03/03/2004 | EP1392367A2 Production and use of a suspension composition comprising an ultrasound contrast medium |
03/03/2004 | EP1392165A1 Wrinkle indicator tape strip and method of using the same |
03/03/2004 | EP1169064B1 Method of detecting endometriosis |
03/03/2004 | EP0938341B1 Compositions and methods for altering the biodistribution of biological agents |
03/02/2004 | US6699040 Material for differently modifying the optical properties of different cells |
03/02/2004 | CA2232879C Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
02/27/2004 | CA2399781A1 Cellular and molecular basis for anti-alzheimer treatment by blocking mrna dendritic transport from cell body to senile plaque and by this the prevention of senile plaque formation |
02/26/2004 | WO2004016751A2 Methods of treating neurodegenerative diseases |
02/26/2004 | WO2004016303A1 Threaded syringe with quick stop |
02/26/2004 | WO2004016156A2 Dynamic hepatic recycling glucose tolerance test |
02/26/2004 | WO2004016154A2 Molecular lymphatic mapping of sentinel lymph nodes |
02/26/2004 | WO2004016148A2 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors |
02/26/2004 | WO2004004636A3 Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis |
02/26/2004 | WO2003096990A3 Protein cages for the delivery of medical imaging and therapy |
02/26/2004 | WO2003057829A3 Methods of generating multispecific, multivalent agents from vh and vl domains |
02/26/2004 | WO2002072636A8 Crystals of whole antibodies and fragments thereof and methods for making and using them |
02/26/2004 | WO2002046418A3 Lipid-associated molecules |
02/26/2004 | US20040040049 Reduction in the formation of the complex in the presence of the candidate agent as compared with in the absence of candidate agent indicates the candidate agent inhibits the binding of LBP-2 to the LBP-2 binding molecule |
02/26/2004 | US20040039281 Method for investigating the fate of a test compound or the stateof a biological system by means of nmr of hyperpolarised nmr active nuclei |
02/26/2004 | US20040039158 Display long emission wavelengths, long decay times, high quantum yields; covalently linked or associated pairs with long life resonance energy transfer donor, ruthenium-ligand complex, and long wavelength acceptor, Texas Red |
02/26/2004 | US20040038964 Imidazole derivatives as raf kinase inhibitors |
02/26/2004 | US20040038920 Which stimulate lymphoctyes specific for myelin basic protein (MBP) autoantigen, which induces severe experimental autoimmune encephalomyelitis in animal models; cytokines |
02/26/2004 | US20040038899 Polymer stabilized neuropeptides |
02/26/2004 | US20040037778 Iodinated and/or brominated derivatives of aromatic dihydroxy monomers are prepared and polymerized to form radio-opaque polymers. The monomers may also be copolymerized with other dihydroxy monomers. The iodinated and brominated aromatic |
02/26/2004 | US20040037777 Small dendrimer-based MRI contrast agents are disclosed to accumulate in renal tubules. The accumulation enables visualization of renal structure and function, permitting assessment of structural and functional damage to the kidneys |
02/26/2004 | CA2494580A1 Threaded syringe with quick stop |
02/25/2004 | EP1391729A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof |
02/25/2004 | EP1391508A1 Transgenic nematode expressing mammalian GPCRS used for screening assay |
02/25/2004 | EP1390405A2 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
02/25/2004 | EP1390391A1 Transporters and ion channels |
02/25/2004 | EP1390080A1 Azo compounds for type i phototherapy |
02/25/2004 | EP1390079A2 Paramagnetic metal ion-based macrocylic contrast agents |
02/25/2004 | EP1390078A1 Ct scanner for imaging a preselected portion of a patient |
02/25/2004 | EP1390077A2 Treatment and diagnosis of macrophage mediated disease |
02/25/2004 | EP1390016A2 Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof |
02/25/2004 | EP1230223B1 Oligobenzimidazole derivatives and their use as dna transfection agents |
02/25/2004 | EP1128812B1 Nano-emulsion of 5-aminolevulinic acid |
02/25/2004 | EP1017704B1 Use of a pentopyranosyl nucleoside containing conjugate for producing an array |
02/25/2004 | EP0954336B1 Membrane incorporation of texaphyrins |
02/25/2004 | CN1478068A Process for preparation of iopamidol and new intermediates therein |
02/25/2004 | CN1139404C Process for preparing iodinated organic X-ray contrast agents |
02/24/2004 | US6696430 Staining eye membranes using dyes selected from trypan blue, trypan red, brilliant cresyl blue or indocyanine green, then removing the membranes; retinopathy |
02/24/2004 | CA2199399C .beta.,.beta.'-dihydroxy meso-substituted chlorins, isobacteriochlorins, bacteriochlorins, and methods for making the same from .beta.,.beta.'-unsubstituted tetrapyrrolic macrocyles |
02/24/2004 | CA2132213C Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
02/24/2004 | CA2125401C Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them |
02/19/2004 | WO2004015392A2 Improved method to identify targeting molecules |
02/19/2004 | WO2004015128A2 Specific shotgun targeting and manipulation of cells and tissues associated with pathogenesis, and libraries for the same |
02/19/2004 | WO2004015072A2 Mrbs as modifiers of the rb pathway and methods of use |
02/19/2004 | WO2004014446A1 Embolization |
02/19/2004 | WO2004014349A1 New molecules for modulating drug resistance in fungus |
02/19/2004 | WO2004014301A2 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
02/19/2004 | WO2003106667A3 Regulation of human subtilase-like serine protease |
02/19/2004 | WO2003065882A3 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts |
02/19/2004 | WO2003059251A3 Antibody targeting compounds |
02/19/2004 | WO2003048384A3 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms |
02/19/2004 | WO2003030947A3 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
02/19/2004 | WO2002091991A3 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use |
02/19/2004 | US20040034007 Use of green porphyrins to treat neovasculature in the eye |
02/19/2004 | US20040033536 Methods for identifying and using insecticides |
02/19/2004 | US20040033345 Water soluble metal and semiconductor nanoparticle complexes |
02/19/2004 | US20040033243 Containing stabilizer, solubilizer, chelator, bulking agent, tonicity adjuster and buffer; fewer degradants; consistent potency |
02/19/2004 | US20040033199 Surrounding a first gas and a second gas with a membrane to form stabilized microbubbles in said liquid, where neither of the gases are water vapor; e.g. perfluoropropane with modifier gas of air and membrane of albumin |
02/19/2004 | US20040033197 Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
02/19/2004 | DE10023051B4 Verfahren zur Herstellung von Fluoresceinisothiocyanat-Sinistrin, dessen Verwendung und Fluoresceinisothiocyanat-Sinistrin enthaltende diagnostische Zubereitung A process for producing fluorescein isothiocyanate-sinistrin, the use of fluorescein isothiocyanate-sinistrin and diagnostic preparation containing |
02/19/2004 | CA2494551A1 Improved method to identify targeting molecules |
02/19/2004 | CA2494252A1 Psmcs as modifiers of the rb pathway and methods of use |
02/18/2004 | EP1389240A2 Mdr1 variants and methods for their use |
02/18/2004 | EP1133494B1 8-azabicyclo 3.2.1]oct-2-ene and -octane derivatives |
02/18/2004 | CN1138591C Coated particles, method of making and using |
02/18/2004 | CN1138566C Contrast agent for magnetic resonant imaging examination of abdomen |